Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the therapy only works for about half of all patients. Until now, there hasn’t been a good way to reliably predict who will benefit and who will not. Researchers at Washington University School of Medicine in…